infective endocarditis (ie)
DESCRIPTION
Infective Endocarditis (IE). Case Presentation November 1, 2000 Sharon Klier, MD Carmel Hospital, Haifa. The Patient. M.L. 76y, male, married+2 Chief complaint : fever, weight loss, cough, weakness for 3 months Present illness : - PowerPoint PPT PresentationTRANSCRIPT
Infective Endocarditis (IE)Infective Endocarditis (IE)
Case Presentation
November 1, 2000
Sharon Klier, MD
Carmel Hospital, Haifa
The PatientThe Patient
M.L. 76y, male, married+2 Chief complaint: fever, weight loss, cough, weakness for 3 months
Present illness: – After Coronary Artery Bypass Graft, aortic valve replacement (AVR) in
1997. AVR was indicated for severe aortic stenosis
– Asymptomatic, no signs of CHF
– Three months prior, episode of fever, cough, diagnosed as left lower lobe (LLL) pneumonia. Treated with antibiotics
– After termination of antibiotic regimen, fever persisted with weakness, anorexia, weight loss of 5 kg for past 3 months
– No chills, headache, arthralgia, skin rash, dysuria, hematuria, shortness of breath, diarrhea, vomiting
Medical historyMedical history
Past medical history:– S/P CABG, AVR 1997
– Coumadin treatment
– Ischemic heart disease: stable angina, FC1
– Hypercholesterolemia
– Hypertension
– Depression
Medications:– Loviran
– Oxopurin
– Pressolat
– Neobloc
– Simovil
– Prizma
– Micropirin
– Coumadin
Physical examinationPhysical examination General appearance: ill-looking, pale, weak, debilitated Vitals: BP: 129/73; pulse:78; RR:18; Temp:36.8c Eyes: pale sclera without petechiae Skin and mucous membranes: petechiae on hard palate, no skin rash, no signs of
systemic emboli Neck: JVP not elevated (10mmHg), positive hepatojugular reflux Heart:
– PMI normal– S2 as expected of artificial valve
– Holosystolic blowing murmur of severe MR, 3/6, maximal at mitral area, radiating to axilla and all other stations
Lungs: dullness on percussion in LLL, crackles ausculated in LLL Abdomen: non tender, hepatomegaly (18 cm), no splenomegaly Limbs: legs and sacral edema Lymph nodes: non enlarged Neurologic: intermittent confusion, no signs of focal neurologic deficit Musculoskeletal: no arthritis
Diagnostic studiesDiagnostic studies Lab:
– CBC: normocytic normochromic anemia, hemoglobin 10g/dL, reticulocytes 2.6, WBC of 9.2x109/L
– Renal function: urea 25mg/dL, creatinine 1.1 g/d
– Liver function: enzymes within normal limits
– Protein electrophoresis: normal Chest X ray:
– Normal size of heart
– LLL infiltrate ECG:
– Normal sinus rhythm
– Normal axis
– Left atrial enlargement
– T wave inversion if inferior leads
– Poor R wave progression from V1 to V4
Diagnostic studiesDiagnostic studies Blood cultures:
– three positive cultures for enterococcus faecalis Abdominal US:
– enlarged prostate with calcification Chest CT:
– little pleural effusion, consolidation in LLL, signs of residual pneumonia
Brain CT:– small lacunar infarcts
Fundus exam:
– no signs of Roth spots
Diagnostic studiesDiagnostic studies
Transthoracic echocardiogram: Normal hemodynamics for prosthetic aortic valve Hyperdynamic left ventricle Mitral annulus calcification Mild mitral stenosis Mild mitral regurgitation
Transesophageal echocardiogram: Ecogenic mass on anterior mitral leaflet on atrial side of about
1cm, suggestive of vegetation Severe MR Good left ventricular contraction Very mild AR
Summary of patientSummary of patient
76 year-old male, 3 year post aortic valve
replacement presented with enterococcal
endocarditis on mitral valve To be discussed: possible explanations
DefinitionDefinition
Infection of the endocardial surface
Implies the physical presence of microorganisms
in the lesion
Heart valves most commonly effected
Acute versus subacute
Etiologic agents in IEEtiologic agents in IE
AgentStreptococci
Viridans streptococci
Enterococci
Other streptococci
Staphylococci
Coagulase positive
Coagulase negative
Gram-negative aerobic bacilli
Fungi
Miscellaneous bacteria
Mixed infections
Culture negative
Percent of cases60-80
30-40
5-18
15-25
20-35
10-27
1-3
1.5-13
2-4
<5
1-2
<5-24
EpidemiologyEpidemiology
Annual incidence: 15,000 to 20,000
Forth leading cause of life-threatening infectious disease
Male:female ratio is 1.7:1
Up to 45% involve mitral valve, 36% aortic valve
0%
10%
20%
30%
40%
50%
60%
Age
Age Distribution
<30 31-60 >60
Predisposing factorsPredisposing factors
Any type of structural heart disease– Rheumatic heart disease (37-76%)– Congenital heart disease (6-24%)– Degenerative cardiac lesions (30-40%)– Other (including prosthetic valves)
PathogenesisPathogenesis
1.Valve surface is altered to produce a suitable site for bacterial attachment and colonization.
2. Platelets and fibrin deposit in the formation of sterile vegetation--the lesions of Nonbacterial Thrombotic Endocarditis (NBTE)
3. Bacteria reach this site and produce colonization.
4. The surface is covered with platelets and fibrin
5. Further bacterial multiplication and vegetation growth
PathophysiologyPathophysiology
Localization of IE is related to:– high pressure areas
– down stream from sites where blood flows at high velocity through a narrow orifice
Transient bacteremia– Occurs whenever a mucosal surface heavily colonized
with bacteria is traumatized
– If preexistent NBTE, it may result in colonization and IE
The interaction between the The interaction between the microorganism and the NBTEmicroorganism and the NBTE
The adherence of the organism to NBTE is a crucial step Organisms more frequently associated with IE adhere
more readily to normal leaflets in vitro1. Dextran production by streptococci may be a virulence factor in
the pathogenesis of IE.
2. FimA is a surface adhesin of S.viridans that serves as an important colonization factor. Homologues of fimA genes were found in many S.viridans strains and enterococci.
3. Fibronectin is implicated as the host receptor within NBTE. Low-fibronectin-binding mutants of S. aureus have decrease ability to produce IE.
The role of plateletsThe role of platelets
Some strains of bacteria are stimulators of platelet aggregation and the release reaction
Platelet-fibrin deposition further enlarges the vegetation once the colonization occurs
Following exposure to thrombin, platelet microbicidal proteins (PMPs) are released.– PMPs show bactericidal activity against some gram-positive cocci
– the resistance to PMP is a potential virulence factor and may contribute to the pathogenesis of IE
– PMPs may act on the bacterial cell membrane/wall synergistically with antibiotics
The role of antibodiesThe role of antibodies
Antibodies against cell surface components reduce the adhesion to fibrin and platelets in vitro and IE in vivo
May depend on the infecting organism
Immunopathologic factorsImmunopathologic factors
IE cause both humural and cellular response Rheumatoid factor:
– titers correlate with the level of hypergammaglobulinemia and decrease with therapy
– possible blocking activity of the IgG opsonic activity (react with the Fc fragment) Antinuclear antibodies:
– may contribute to the musculoskeletal manifestations, low-grade fever, or pleuritic pain
Circulating immune complexes:– Connected with long duration of illness, extravascular manifestations,
hypocomplemenemia– May cause diffuse glomerulonephritis, and some of the peripheral manifestations
such as Osler nodes
Pathologic changes: HeartPathologic changes: Heart
Vegetation location: along the line of closure of a valve leaflet Mitral valve more common; anterior leaflet more common Lesion consists primarily of: fibrin, platelet aggregates, and bacterial
masses With treatment, healing occurs by fibrosis and occasionally
calcification Infection may lead to leaflet perforation, rupture of chordae tendinae,
interventricular septum, or papillary muscle Embolic phenomena are common (15-35%). Most frequently
involving: renal, splenic, coronary, or cerebral circulation. Risk for emboli is increased when vegetation >1cm.
Pathologic changes: KidneyPathologic changes: Kidney
Pathological processes: abscess, infarction, glomerulonephritis (focal, segmental), membranoproliferative GN
May be normal is size or slightly swollen 10 to 15% of IE exhibit immune complex GN (as in
SLE). Supporting IC rather than emboli:1. Bacteria rarely seen in lesion2. GN can occur with right-sided IE3. GN is rare in acute IE even though large vegetation result in
metastatic abscess formation4. IF staining reveals IC-typical distribution5. Antibacterial antibodies eluted from lesions
Pathologic changes:Pathologic changes:Mycotic aneurysmsMycotic aneurysms
Develop during active IE More common with S.viridans May arise by the following mechanisms:
– direct bacterial invasion of the arterial wall with subsequent abscess formation or rupture
– septic or bland emoblic occlusion of the vasa vasorum– immune complex deposition with resultant injury to arterial
wall Tend to occur at bifurcation areas; middle cerebral
artery is most common Clinically silent until rupture
Pathologic changesPathologic changes
CNS– cerebral emboli (>30% of IE)– mycotic aneurysms
Spleen– infarctions (44% of autopsy cases)– enlargement associated with hyperplasia of lymphoid follicles,
increase in secondary follicles, focal necrosis– abscess
Lung– associated with right-sided IE– pulmonary embolism, acute pneumonia, pleural effusion, or empyema
Pathologic changesPathologic changes
Skin– petechiae, may result from local vasculitis or emboli
– Osler nodes, painful nodes on finger or toe pads
– immune complexes in dermal vessels
– Janeway lesions (due to septic emboli), painless plaques on palms or soles
– splinter hemorrhage (linear lines beneath fingernails)
Eye– Roth spots
Clinical manifestationsClinical manifestations
Contributed by these processes:1. The infectious process on the valve, including
the local intracardiac complications
2. Bland or septic embolization to any organ
3. Constant bacteremia
4. Circulating immune complexes
Clinical manifestationsClinical manifestations Fever, rarely >400c (>95%) Nonspecific symptoms (weakness, weight loss, night sweats) Audible heart murmur (>85% of cases) Petechiae (20-40%) Osler nodes (10-25%) Janeway lesions (<5%) Splinter hemorrhages (10-30%) Roth spots (<5%) Clubbing (10-20%) Splenomegaly (25-60%) Musculoskeletal manifestations (25-45%) Major embolic episodes (>30%) Neurologic deficits
Lab findingsLab findings Hematology
Anemia: normochromic, normocytic, low serum iron, low iron-binding capacity (70-90%)
– Thrombocytopenia (5-15%)– Leukocytosis (20-30%)– Histiocytes (>25%)– Elevated ESR, with mean value of 57mm/hr (90-100%)– Hypergammaglobulinemia (20-30%)
Urinalysis– Proteinuria (50-65%)– Microscopic hematuria (30-60%)– Red cell casts (12%)
Lab findingsLab findings
Serology– Rheumatoid factor (40-50%)
– Circulating immune complexes
– Antinuclear antibodies
– Complement
Blood culture– Most important lab test
– Positive cultures in 97% of cases
ProceduresProcedures Echo
– TTE is rapid, noninvasive specificity: 98% sensitivity: <60%
– TEE higher ultrasonic frequencies, improve spatial resolution specificity: 94% (prosthetic valve: 88-100%) sensitivity: 76-100% (prosthetic valve: 86-94%)
Cath– hemodyanmic and anatomic info for surgical
intervention
Duke Criteria for IE diagnosisDuke Criteria for IE diagnosisMajor criteria Positive blood culture for infective endocarditis
– Typical microorganism for IE from 2 separte blood cultures Viridans streptococci, Streptococcus bovis, HACEK group or, Community-acquired staphylococcus aureus or enterococci, in the absence of a primary
focus, or Persistently positvie blood cultures for any microorganism, or All of 3, or majority of 4 or more separate blood cultures, with first and last
specimens drawn at least 1 hour apart Evidence of endocardial involvement
– Findings on echo positive for IE Oscillating intracardiac mass on valve or supporting structures or in the path of regurgitant
jets, or on iatrogenic devices, in the absence of an alternative anatomic explanation, or Abscess, or New partial dehiscence of prosthetic valve, or
– New valvular regurgitation
Duke Criteria for IE diagnosisDuke Criteria for IE diagnosis
Minor criteria Predisposition: predisposing heart condition or intravenous drug use Fever: >38°c Vascular phenomena: arterial embolism, septic pulmonary infarcts, mycotic
aneurysm, intracranial hemorrhage, Janeway lesions Immunological phenomena: glomerulnephritis, Osler nodes, Roth spots,
rheumatoid factor Echocardiogram: findings consistent with IE but not meeting major criterion
above Microbiologic evidence: positive blood culture but not meeting major criterion
above, or serologic evidence of active infection with organism consistent with IE
Enterococcus as an etiologic Enterococcus as an etiologic agentagent
Normal inhabitants of the GI tract, occasionally anterior urethra Catalase negative and non-motile Grow well in sodium azide, 40% bile, 6.5% NaCl, 0.1% methylene blue, and
can survive at 56c for 30 minutes or at pH of 9.6. Responsible for 5-18% of IE Mostly subacute and affect men (mean age 59) after genitourinary
manipulations or women (mean age 37) after obstetrics procedures >40% of patients have no underlying heart disease, but 95% will develop a
heart murmur Classic peripheral signs are uncommon (<25%) Cure is difficult because of intrinsic resistance to many antibiotics E. faecalis 85% of enterococcal IE
TherapyTherapy
Complete eradication takes weeks, relapses may occur. This is due to:1. The infection exists in an area of impaired host defense and is
tightly encased in a fibrin meshwork
2. The bacteria reach very high population densities, such that the organism may exist in a state of reduced metabolic activity and cell division
Aspirin may decrease the growth of vegetative lesions and prevent cerebral emboli
Therapy: General principlesTherapy: General principles Etiologic agent must be isolated in pure culture. MIC and MBC should
be determined Parenteral antibiotics are recommended over oral drugs Bacteriostatic antibiotics are generally ineffective Antibiotic combinations should produce a rapid effect Selection of antibiotics should be based on susceptibility tests, and
treatment should be monitored clinically and with antimicrobial blood levels
Blood cultures should be obtained during the early phase of therapy to ensure eradication
Use of anticoagulants during therapy for native valve IE is not recommended. With mechanical valves, anticoagulation should be maintained (if indicated) within therapeutic range
Therapy of enterococcal IETherapy of enterococcal IE Enteraococci is the third most common form of IE and the most
resistant to therapy. Mortality rate is 20%. Relapses may occur. Cell wall active antibiotics plus an aminoglycoside are synergistic
and produce a bacteriocidal effect against most strains General accepted regimen:
– Penicillin G, 18-30 million units/day IV, or ampicilline, 12g/d IV, in divided doses q4d, plus gentamycin, 1mg/kg IV q8d, both X 4-6 weeks
– Vancomycin, 15mg/kg IV q12d, plus gentamyicn as above, both 4 to 6 weeks.
Prognostic signsPrognostic signs
S. aureus, fungal infections Previous IE Cyanotic heart disease CHF Embolic phenomena Rupture of a mycotic aneurysm Lack of response to antimicrobial therapy Prosthetic valve endocarditis Periannular extension of infection
Surgical therapy:Surgical therapy:IndicationsIndications
refractory CHF >2 serious systemic embolic episode uncontrolled infection physiologically significant valve dysfunction as demonstrated
by echo ineffective antimicrobial therapy resection of mycotic aneurysms most cases of prosthetic valve IE (caused by more antibiotic-
resistant pathogens) local suppurative complications including perivalvular or
myocardial abscesses
Surgical therapy:Surgical therapy:Echo featuresEcho features
Persistent vegetations after a major systemic embolic episode
Large (>1cm diameter) anterior mitral valve vegetation
Increase in vegetation size 4 weeks after antibiotic therapy
Acute mitral insufficiency Valve perforation or rupture Periannular extension of infection
The PatientThe Patient
MIC of E. faecalis– Vancomycin 2 g– Penicilline 1 g – Gentamycin 3 g
Choice of therapy:– Ampicillin: 2g x 6– Gentamycin: 60mg x 3 later 60mg/18h
Course of treatment:– creatinine level increased to 1.8g/d– DD: nephrotoxicity, GN, embolic abscess, ACE inhibitor toxicity
RBC casts negative -- rule out GN if complement level normal -- suggests toxicity if complement decrease -- suggests IC complication lack of physical signs (hematuria, fever, pain) -- rule out embolic abscess
– Treatment + 3 days: blood culture is positive– Treatment + 10 days: blood culture is negative but pending
Patient with AVR but Patient with AVR but IE on native valveIE on native valve
Possible explanations:– Technical limitation - vegetation not detected
– Mitral valve was stenotic and regurgitant
– Complete emboli from aortic valve
ConclusionsConclusions
No absolute indications for surgery, however, it may be suggestive due to:– Location of vegetation
– Severe mitral regurgitation
Needs a follow up echo to determine:– Vegetation size (currently borderline)
– Mitral regurgitation severity
– Aortic valve condition
– Local complications